Mawia Osman | Quantum Chemistry | Research Excellence Award

Published on by Research Chemistry Awards

Dr. Mawia Osman | Quantum Chemistry | Research Excellence Award

China West Normal University, China

Dr. Mawia Osman is a dedicated researcher in advanced mathematical sciences, recognized for her work at the intersection of fuzzy systems, nonlinear dynamics, and computational analysis. She built a strong academic foundation through a BSc in Science and Technology, followed by qualifying studies in mathematical sciences, an MSc in pure and applied sciences, and a PhD in Mathematics and Statistics from Northwest Normal University, China. Her doctoral journey was supported by the prestigious Chinese Government Scholarship (CSC), awarded for excellence and potential in research. Throughout her academic progression, she has developed expertise in fuzzy analysis, fuzzy differential and fractional differential equations, nonlinear partial differential equations, fuzzy integral equations, and numerical analysis. Her broader research interests also extend to fuzzy mathematical modeling, quantum calculus, fractal calculus, nonlinear analysis, and biomedical research, reflecting a multidisciplinary vision. Dr. Osman’s scholarly work contributes to solving complex real-world problems using advanced mathematical frameworks, positioning her as a promising researcher in modern applied mathematics. Her commitment to research, continuous learning, and innovative thinking defines her professional identity, and she remains focused on expanding the theoretical and practical applications of fuzzy and nonlinear systems in scientific and technological advancements.

Profiles: Orcid | Google Scholar

Featured Publications

Shah, S.O., Tikare, S., & Osman, M. (2023). Ulam Type Stability Results of Nonlinear Impulsive Volterra–Fredholm Integro-Dynamic Adjoint Equations on Time Scale. Mathematics, 11(21).

Ali, U., & Osman, M. (2023). On Consequences of Carreau Nanofluid Model with Dufour–Soret Effects and Activation Energy Subject to New Mass Flux Condition: A Numerical Study. Mathematics, 11(11).

Osman, M., Xia, Y., Omer, O.A., & Hamoud, A. (2022). On the Fuzzy Solution of Linear–Nonlinear Partial Differential Equations. Mathematics, 10(13).

Omer, O.A., Saibi, K., Abidin, M.Z., & Osman, M. (2022). Parametric Marcinkiewicz Integral and Its Higher-Order Commutators on Variable Exponents Morrey–Herz Spaces. Journal of Function Spaces, Article 7209977.

Osman, M., Almahi, A., Omer, O.A., Mustafa, A.M., & Altaie, S.A. (2022). Approximation Solution for Fuzzy Fractional-Order Partial Differential Equations. Fractal and Fractional, 6(11).

Osman, M., Xia, Y., Marwan, M., & Omer, O.A. (2022). Novel Approaches for Solving Fuzzy Fractional Partial Differential Equations. Fractal and Fractional, 6(11).

Osman, M., Gong, Z., Mustafa, A.M., & Yang, H. (2021). Solving Fuzzy (1+n)-Dimensional Burgers’ Equation. Advances in Difference Equations, Article 3376.

Helton Santiago | Inflammation | Research Excellence Award

Published on by Research Chemistry Awards

Assoc. Prof. Dr. Helton Santiago | Inflammation | Research Excellence Award

Federal University of Minas Gerais | Brazil

Assoc. Prof. Dr. Helton Santiago is a distinguished immunologist whose career bridges clinical research, infectious disease immunology, and vaccine development. He earned his medical degree followed by a master’s and Ph.D. in Immunology of Infectious Diseases, later completing advanced postdoctoral training in leading U.S. institutions, where he deepened his expertise in parasitic diseases, allergy, and immune regulation. Over the years, he has held key academic and research positions, including roles at renowned universities and national research institutes, contributing to major programs in dengue, Zika, COVID-19, helminth infections, Chagas disease, and leishmaniasis. His experience spans directing clinical trials, leading Phase I–III vaccine studies, developing early-stage vaccine candidates, and conducting translational research on regulatory T cells, cytokines, biomarkers, allergy, inflammation, and cancer immunology. His scientific leadership is reflected in service on ethics committees, biosafety boards, IRBs, and clinical trial oversight groups. Dr. Santiago’s innovative contributions have earned multiple national and international awards, including recognitions for medical innovation, scientific merit, and outstanding doctoral research. His work continues to advance understanding of immune mechanisms and support the development of groundbreaking vaccines and therapeutic strategies, reinforcing his role as a prominent figure in global immunology and translational medicine.

Profiles: Scopus | Google Scholar

Featured Publications

Bafica, A., Santiago, H. C., Goldszmid, R., Ropert, C., Gazzinelli, R. T., & Sher, A. (2006). “TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection” in The Journal of Immunology.

Diemert, D. J., Pinto, A. G., Freire, J., Jariwala, A., Santiago, H., Hamilton, R. G., Periago, M. V., Loukas, A., Tribolet, L., Mulvenna, J., Correa-Oliveira, R., Hotez, P. J., & Bethony, J. M. (2012). “Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths” in Journal of Allergy and Clinical Immunology.

Canesso, M. C. C., Lemos, L., Neves, T. C., Marim, F. M., Castro, T. B. R., Veloso, É. S., Queiroz, C. P., Ahn, J., Santiago, H. C., Martins, F. S., Alves-Silva, J., Ferreira, E., Cara, D. C., Vieira, A. T., Barber, G. N., Oliveira, S. C., & Faria, A. M. C. (2018). “The cytosolic sensor STING is required for intestinal homeostasis and control of inflammation” in Mucosal Immunology.

Dos Santos, P. V. A., Roffê, E., Santiago, H. C., Torres, R. A., Marino, A. P. M. P., Paiva, C. N., Silva, A. A., Gazzinelli, R. T., & Lannes-Vieira, J. (2001). “Prevalence of CD8⁺ αβ T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L⁻LFA-1⁺VLA-4⁺ activation phenotype and expression of IFN-γ” in Microbes and Infection.

Santiago, H. C., Feng, C. G., Bafica, A., Roffe, E., Arantes, R. M., Cheever, A., Taylor, G., Vieira, L. Q., Aliberti, J., Gazzinelli, R. T., & Sher, A. (2005). “Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth” in The Journal of Immunology.

Bethony, J. M., Simon, G., Diemert, D. J., Parenti, D., Desrosiers, A., Schuck, S., Fujiwara, R., Santiago, H., & Hotez, P. J. (2008). “Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults” in Vaccine.

Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Published on by Research Chemistry Awards

Mrs. Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Hilab | Brazil

Mrs. Aléxia Thamara Gasparin is a dedicated biotechnology and pharmacology professional whose academic and research journey reflects strong commitment to scientific advancement and health innovation. She holds a technical qualification in Biotechnology and Industrial Bioprocesses from SENAI-PR, a Bachelor’s degree in Biological Sciences from the Federal University of Paraná (UFPR), and a Master’s degree in Pharmacology from UFPR. Throughout her education, she developed extensive laboratory expertise, particularly in evaluating the pharmacological potential and adverse effects of bioactive compounds, and she actively participated in specialized training programs in pharmacology, psychopharmacotherapy, epigenetics, and animal handling. Her professional experience includes significant contributions to research projects focused on antinociceptive and anti-inflammatory mechanisms, as well as the development of interactive and didactic scientific materials. She also played a key role in science outreach and health-related extension activities. Currently, she is part of the research and development team at Hilab, where she contributes to the innovation of remotely operated laboratory tests (RTL) and internationally patented products designed to expand access to healthcare technologies in Brazil. Her achievements include top rankings and awards in scientific presentation events, highlighting her proficiency and dedication. Aléxia continues to build a meaningful career focused on pharmacology, biotechnology, and health democratization.

Profile: Scopus

Featured Publication

Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis

Author: Cannabis and Cannabinoid Research

Year: 2024

Nicholas Candy | Surgical Hydrogels | Research Excellence Award

Published on by Research Chemistry Awards

Dr. Nicholas Candy | Surgical Hydrogels | Research Excellence Award

University of Adelaide | Australia

Dr. Nicholas Candy is an accomplished neurosurgeon and academic whose career blends advanced clinical expertise with impactful research. He holds a Master of Surgery in Neurosurgery from the University of Sydney and completed his PhD at the University of Adelaide, where he later progressed to roles as Clinical Lecturer and Senior Clinical Lecturer. His extensive clinical experience spans multiple accredited registrar positions across leading Australian hospitals, including the Royal Adelaide Hospital, Royal Brisbane and Women’s Hospital, and Flinders Medical Centre. He has cultivated strong research interests in pituitary surgery, postoperative outcomes, neuro-endocrine preservation, and innovations that reduce surgical scarring and complications. His role as Coordinating Principal Investigator in a Phase I trial on Chitogel and Deferiprone Gel reflects his commitment to translational research designed to enhance neurosurgical recovery. Dr. Candy has supervised doctoral research, contributed to international clinical studies, and carried out significant work in traumatic brain injury outcomes and neurosurgical quality-of-life assessments. His academic impact and contributions have earned him notable awards, including multiple prestigious research scholarships from the Royal Australasian College of Surgeons and recognition as the Sheldon College Young Alumnus of the Year. Overall, he stands out as a dedicated clinician-scientist advancing modern neurosurgical practice.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Ovenden, C., Mignone, E., Chapman, I., Torpy, D. J., Rankin, W., Jukes, A., Santoreneos, S., Candy, N., Psaltis, A., & De Sousa, S. M. C. (2026). “Early Postoperative Decline in Insulin-Like Growth Factor 1 (IGF-1) Predicts Surgical Remission of Acromegaly.” World Neurosurgery.

Candy, N. G., Barry, E. F., Tomatis, V. M., Patel, S., Miller, J., Ovenden, C., Nowicki, J., Hammam, E., Poonnoose, S., Sandler, S., et al. (2025). “Phase I Trial to Evaluate Safety of Deferiprone-Chitogel to Prevent Epidural Fibrosis in Lumbar Spine Surgery.” European Spine Journal.

Tong, J. Y., Candy, N. G., Sung, J., Jukes, A. K., & Selva, D. (2025). “In Reply: Transorbital Approach to the Cavernous Sinus After an Exenteration.” Operative Neurosurgery.

Tong, J. Y., Candy, N. G., Sung, J., Jukes, A. K., & Selva, D. (2025). “Transorbital Approach to the Cavernous Sinus After an Exenteration.” Operative Neurosurgery.

Candy, N. G., Jukes, A. K., Ooi, E. H., Valentine, R., Vrodos, N., Santoreneos, S., Floreani, S., Wormald, P.-J., & Psaltis, A. J. (2025). “The Evolution of Pituitary Surgery in an Australian Health Care Framework.” Journal of Neurological Surgery Part B: Skull Base.

Candy, N. G., Zhang, A. S., Jukes, A. K., & Wormald, P. J. (2025). “Sphenoid sinusitis with extradural empyema in a paediatric patient.” Journal of Clinical Neuroscience.

Mansour, L. T., Candy, N., Nowicki, J., Jukes, A., Chryssidis, S., & Harding, M. (2024). “An infratentorial dural arteriovenous fistula mimicking cervical myelopathy: A case report.” Clinical Neurology and Neurosurgery.

Harishchander | Biosensing | Best Researcher Award

Published on by Research Chemistry Awards

Dr. Harishchander | Biosensing | Best Researcher Award

Amrita Vishwa Vidyapeetham | India

Dr. Harishchander is an accomplished academic and researcher in bioengineering and bioinformatics, recognized for his strong interdisciplinary expertise and impactful scientific contributions. He holds a B.Tech and M.Tech in Bioinformatics and earned his Ph.D. in Bioengineering, building a solid foundation in computational biology, systems biology, and biomedical data analysis. With extensive experience as a researcher, keynote speaker, session chair, judge, and committee member across numerous national and international scientific events, he has actively contributed to advancing research communities. His research interests span computational bioengineering, biomarker analytics, machine learning applications in biology, therapeutic peptide analysis, biological network modeling, microRNA-based regulation, infectious diseases, and integrative genomics. Dr. Harishchander has authored multiple Scopus-indexed publications and received numerous prestigious honors, including the AIRA Award, Outstanding Scientist Award, Best Innovation Award, Young Investigator Award, Best Researcher Award, Distinguished Professor Award, and several Best Paper Awards across diverse domains. His achievements also include global recognition in photography and excellence awards for academic service, innovation, peer reviewing, and scientific contributions. Driven by scientific curiosity and multidisciplinary thinking, he continues to contribute to the advancement of bioengineering research and remains committed to fostering innovation, collaboration, and impactful knowledge dissemination.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Baseer, K. K., Reddy, N. R., Kumar, T. S., Anandaram, H., & Panthakkan, A. (2025). AI, IoT, and Cognitive Computing for Mental Health Enhancement and Object Detection.

Anandaram, H., Shreenidhi, K. S., Joshi, K., Sidhu, K. S., Kiruthigha, R., Singh, V., & Tripathi, A. (2025). A Case Study on Resource Management Industrial IoT Application.

Ashok, P., Bharati, A. P., Velpula, S., Krishna, K. M., Sridevi, S. L., Patchala, S., Gopinath, S., & Anandaram, H. (2025). Integrated 5G and Edge Computing Framework for Low-Latency IoT Applications.

Anandaram, H., Sidhu, K. S., Kiruthigha, R., Pathak, N., Sudhakar, A., Sharma, N., & Joshi, K. (2025). Analysis of the Human Brain Using Basic Computer Interface (BCI) System.

Pathak, N., Sharma, N., Sahoo, D. R., Alam, F., Anandaram, H., & Joshi, K. (2025). Fundamentals Approached Towards Artificial Neural Networks in Brain Computer Interface.

Kausar, M. T. A., Anandaram, H., Sidhu, K. S., Pathak, N., Sudhakar, A., Sharma, N., & Joshi, K. (2025). Introduction of a Cutting-Edge Technology Neural Networks Organization.

Sindhuja, L. S., Shreenidhi, K. S., Anandaram, H., Chandra, S., & Hari, B. S. (2025). Optimizing Composite Material Selection Using the Artificial Bee Colony Algorithm.

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Published on by Research Chemistry Awards

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Changzhou University | China

Dr. Hongyan Lin is a distinguished researcher and lecturer at the School of Pharmaceutical Sciences, Changzhou University, China, with a strong emphasis on natural product chemistry and molecular pharmacology. She completed her Bachelor’s degree in Bioengineering at Changzhou University, followed by an Integrated Master-PhD in Biology at Nanjing University, where she specialized in the biological mechanisms of traditional medicine. Dr. Lin further expanded her expertise as a Postdoctoral Fellow and Research Associate at the School of Life Sciences, Nanjing University, contributing significantly to molecular pharmacology and natural product research. Her research interests focus on the chemical structural modification of natural products for anticancer applications, the role of traditional Chinese medicine in regulating intestinal microbiota to prevent colitis-associated cancer, and the isolation, structural identification, and biological activity of bioactive compounds from traditional herbs. Dr. Lin has been recognized for her scientific contributions through research grants and academic publications in high-impact journals. Her work supports the evolution of natural product-based therapeutics and offers promising directions for cancer prevention and treatment. In her role as a lecturer and researcher, she continues to inspire the next generation of pharmaceutical scientists through her dedication and innovation.

Profiles: Scopus | Orcid

Featured Publications

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products, Published online July 28, 2023.

Lin, H., Zhou, Z., Ma, X., Chen, Q., Han, H., Wang, X., Qi, J., & Yang, Y. (2021). One pot synthesis of aryl nitriles from aromatic aldehydes in a water environment. RSC Advances, 2021.

Prof. Jianli Liu | Chemical Toxicology | Best Researcher Award

Published on by Research Chemistry Awards

Prof. Jianli Liu | Chemical Toxicology | Best Researcher Award

Liaoning University | China

Prof. Jianli Liu is a distinguished researcher and educator in the field of biotechnology and medical genetics, with a strong academic foundation spanning from a Bachelor’s and Master’s degree in Biotechnology at Shenyang Agricultural University to a Ph.D. in Medical Genetics from China Medical University, where his doctoral work focused on CDK2 expression regulated by STK15 in laryngeal carcinoma. He began his academic career as a tutor at Liaoning University, advancing through the roles of lecturer and associate professor, and currently serves as a professor at the Life Science School of Liaoning University. Prof. Liu’s research interests lie in molecular mechanisms of disease, cellular signaling pathways, and the protective effects of natural products such as polysaccharides, anthocyanins, and polyphenols against environmental stressors including high glucose and PM2.5-induced damage. He has led multiple nationally funded projects, including those supported by the National Natural Science Foundation of China and regional innovation programs, focusing on lung disease, β-cell protection, heavy metal pollution control, and therapeutic potentials of bioactive compounds. Recognized for his impactful contributions, Prof. Liu continues to advance interdisciplinary research bridging biotechnology, medicine, and environmental health, while inspiring future scientists through his teaching and mentorship.

Profile: Scopus

Featured Publications

Study on the causality of cathepsin on autoimmune diseases and cancer: evidence from mendelian randomization analysis

Cadmium induces the secretion of SASP factors regulated by MAPK and NF-κB signaling pathways in HEK293 cells: A possible mechanism of acute kidney damage induced by cadmium

Genetic Association of Chronic Pains and Analgesics With Telomere Length: A Mendelian Randomization Study

Cadmium exposure induces inflammation, oxidative stress and DNA damage in HUVEC and promotes THP-1 adhesion: A possible mechanism on the formation of atherosclerotic plaque

Assessments of Pollution Status and Human Health Risk of Potentially Toxic Elements in Primary Crops and Agricultural Soils in Guanajuato, Mexico

Association between cadmium exposure and the risk of cardiovascular outcomes: a meta-analysis